Prodotti GS / Area Liver
Paediatric line extension LD tablets & 12 to <18 years indication
![Immagine News](/media/0icnkhat/cat-1.jpg?center=0.55476190476190479,0.25&mode=crop&width=722&height=442)
EC Decision: 16 September 2021
Vosevi received Paediatric Line Extension.
Extension of indication to the existing presentation of 400/100/100 mg film-coated tablets for Vosevi
- a new strength: 200/50/50 mg film-coated tablets
- the extension of indication for the treatment of chronic hepatitis C virus (HCV) infection to include paediatric use in in patients aged 12 years and older and weighing at least 30 kg.
Grazie per il tuo feedback!